The future of this treatment
In other words, this means that when new medications such as PCM 075 come out they are often tested on their own and in combination with other treatments such as HDAC inhibitors. PCM-075 was also tested with multiple other types of cancer treatments. The current preclinical data is positive and indicates that this new medication could be used to treat a variety of cancer types. Clinical trials will begin by looking at the effect that PCM 075 has on AML.